Oral prodrug enters cephalosporin market.
Thompson
C A
CA
D000284:Administration, Oral; D001424:Bacterial Infections / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy; D002511:Cephalosporins / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D017277:Drug Approval; D004347:Drug Interactions; D006801:Humans; D010612:Pharyngitis / Q000188:drug therapy; D011355:Prodrugs / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D017192:Skin Diseases, Bacterial / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
D002511:Cephalosporins; D011355:Prodrugs; C073460:cefditoren